Literature DB >> 24403077

Developmental onset of bilirubin-induced neurotoxicity involves Toll-like receptor 2-dependent signaling in humanized UDP-glucuronosyltransferase1 mice.

Mei-Fei Yueh1, Shujuan Chen, Nghia Nguyen, Robert H Tukey.   

Abstract

Biological and signaling events that connect developmentally induced hyperbilirubinemia to bilirubin-induced neurological dysfunction (BIND) and CNS toxicity in humans are poorly understood. In mammals, UDP-glucuronosyltransferase 1A1 (UGT1A1) is the sole enzyme responsible for bilirubin glucuronidation, a rate-limiting step necessary for bilirubin metabolism and clearance. Humanized mice that express the entire UGT1 locus (hUGT1) and the UGT1A1 gene, develop neonatal hyperbilirubinemia, with 8-10% of hUGT1 mice succumbing to CNS damage, a phenotype that is presented by uncontrollable seizures. We demonstrate that neuroinflammation and reactive gliosis are prominent features of bilirubin brain toxicity, and a disturbed redox status resulting from activation of NADPH oxidase is an important contributing mechanism found in BIND. Using knock-out mice and primary brain cells, we connect a key pattern recognition receptor, Toll-like receptor 2 (TLR2), to hyperbilirubinemia-induced signaling. We illustrate a requirement for TLR2 signaling in regulating gliosis, proinflammatory mediators, and oxidative stress when neonatal mice encounter severe hyperbilirubinemia. TLR2-mediated gliosis strongly correlates with pronounced neuroinflammation in the CNS with up-regulation of TNFα, IL-1β, and IL-6, creating a pro-inflammatory CNS environment. Gene expression and immunohistochemistry staining show that hUGT1/Tlr2(-/-) mice fail to activate glial cells, proinflammatory cytokines, and stress response genes. In addition, bilirubin-induced apoptosis was significantly enhanced by blocking TLR2 signaling indicating its anti-apoptotic property. Consequently, a higher neonatal death rate (57.1%) in hUGT1/Tlr2(-/-) mice was observed when compared with hUGT1 mice (8.7%). These results suggest that TLR2 signaling and microglia neuroinflammation are linked to a repair and/or protection mode against BIND.

Entities:  

Keywords:  Brain; Glia; Neuroinflammation; Oxidative Stress; Toll-like Receptors (TLR); UDP-glucuronosyltransferase

Mesh:

Substances:

Year:  2014        PMID: 24403077      PMCID: PMC3931032          DOI: 10.1074/jbc.M113.518613

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Pattern recognition receptors: doubling up for the innate immune response.

Authors:  Siamon Gordon
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

Review 2.  Toll-like receptor signaling in neural plasticity and disease.

Authors:  Eitan Okun; Kathleen J Griffioen; Mark P Mattson
Journal:  Trends Neurosci       Date:  2011-03-16       Impact factor: 13.837

3.  Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury.

Authors:  Seiji Okada; Masaya Nakamura; Hiroyuki Katoh; Tamaki Miyao; Takuya Shimazaki; Ken Ishii; Junichi Yamane; Akihiko Yoshimura; Yukihide Iwamoto; Yoshiaki Toyama; Hideyuki Okano
Journal:  Nat Med       Date:  2006-06-18       Impact factor: 53.440

Review 4.  Sterile inflammation: sensing and reacting to damage.

Authors:  Grace Y Chen; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

Review 5.  Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.

Authors:  A Kadakol; S S Ghosh; B S Sappal; G Sharma; J R Chowdhury; N R Chowdhury
Journal:  Hum Mutat       Date:  2000-10       Impact factor: 4.878

6.  NADPH oxidase immunoreactivity in the mouse brain.

Authors:  Faridis Serrano; Nutan S Kolluri; Frans B Wientjes; J Patrick Card; Eric Klann
Journal:  Brain Res       Date:  2003-10-24       Impact factor: 3.252

7.  Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries.

Authors:  Isaias Glezer; Amelie Lapointe; Serge Rivest
Journal:  FASEB J       Date:  2006-02-07       Impact factor: 5.191

Review 8.  Microglia as a source and target of cytokines.

Authors:  Uwe-Karsten Hanisch
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

Review 9.  Heterogeneity of microglial activation in the innate immune response in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-05       Impact factor: 4.147

10.  Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.

Authors:  Yumiko Imai; Keiji Kuba; G Greg Neely; Rubina Yaghubian-Malhami; Thomas Perkmann; Geert van Loo; Maria Ermolaeva; Ruud Veldhuizen; Y H Connie Leung; Hongliang Wang; Haolin Liu; Yang Sun; Manolis Pasparakis; Manfred Kopf; Christin Mech; Sina Bavari; J S Malik Peiris; Arthur S Slutsky; Shizuo Akira; Malin Hultqvist; Rikard Holmdahl; John Nicholls; Chengyu Jiang; Christoph J Binder; Josef M Penninger
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

View more
  17 in total

Review 1.  Magnetic resonance imaging of bilirubin encephalopathy: current limitations and future promise.

Authors:  Jessica L Wisnowski; Ashok Panigrahy; Michael J Painter; Jon F Watchko
Journal:  Semin Perinatol       Date:  2014-09-27       Impact factor: 3.300

2.  Reduced Myelination and Increased Glia Reactivity Resulting from Severe Neonatal Hyperbilirubinemia.

Authors:  Andreia Barateiro; Shujuan Chen; Mei-Fei Yueh; Adelaide Fernandes; Helena Sofia Domingues; João Relvas; Olivier Barbier; Nghia Nguyen; Robert H Tukey; Dora Brites
Journal:  Mol Pharmacol       Date:  2015-10-19       Impact factor: 4.436

3.  The commonly used antimicrobial additive triclosan is a liver tumor promoter.

Authors:  Mei-Fei Yueh; Koji Taniguchi; Shujuan Chen; Ronald M Evans; Bruce D Hammock; Michael Karin; Robert H Tukey
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

Review 4.  Developmental, Genetic, Dietary, and Xenobiotic Influences on Neonatal Hyperbilirubinemia.

Authors:  Mei-Fei Yueh; Shujuan Chen; Nghia Nguyen; Robert H Tukey
Journal:  Mol Pharmacol       Date:  2017-03-10       Impact factor: 4.436

5.  Chemoprevention of bilirubin encephalopathy with a nanoceutical agent.

Authors:  Aniruddha Adhikari; Vinod K Bhutani; Susmita Mondal; Monojit Das; Soumendra Darbar; Ria Ghosh; Nabarun Polley; Anjan Kumar Das; Siddhartha Sankar Bhattacharya; Debasish Pal; Asim Kumar Mallick; Samir Kumar Pal
Journal:  Pediatr Res       Date:  2022-07-06       Impact factor: 3.756

6.  Cadmium and arsenic override NF-κB developmental regulation of the intestinal UGT1A1 gene and control of hyperbilirubinemia.

Authors:  Miao Liu; Shujuan Chen; Mei-Fei Yueh; Ryoichi Fujiwara; Camille Konopnicki; Haiping Hao; Robert H Tukey
Journal:  Biochem Pharmacol       Date:  2016-04-06       Impact factor: 5.858

Review 7.  Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia.

Authors:  Ryoichi Fujiwara; Yoshihiro Maruo; Shujuan Chen; Robert H Tukey
Journal:  Toxicol Appl Pharmacol       Date:  2015-09-02       Impact factor: 4.219

8.  The Blockade of NF-κB Activation by a Specific Inhibitory Peptide Has a Strong Neuroprotective Role in a Sprague-Dawley Rat Kernicterus Model.

Authors:  Mengwen Li; Sijie Song; Shengjun Li; Jie Feng; Ziyu Hua
Journal:  J Biol Chem       Date:  2015-10-23       Impact factor: 5.157

9.  Differential Role of Liver X Receptor (LXR) α and LXRβ in the Regulation of UDP-Glucuronosyltransferase 1A1 in Humanized UGT1 Mice.

Authors:  Eva Hansmann; Elvira Mennillo; Emiko Yoda; Mélanie Verreault; Olivier Barbier; Shujuan Chen; Robert H Tukey
Journal:  Drug Metab Dispos       Date:  2020-01-24       Impact factor: 3.922

10.  Amplitude of low-frequency fluctuation may be an early predictor of delayed motor development due to neonatal hyperbilirubinemia: a fMRI study.

Authors:  Kai Yan; Feifan Xiao; Yuwei Jiang; Chunmei Lu; Yong Zhang; Yanting Kong; Jian Zhou; Junbo Wang; Chengxiang Lin; Haowei Yang; Dajiang Zhang; Guoqiang Cheng; Zhongwei Qiao; Liping Wang; Qian Qin; Wenhao Zhou
Journal:  Transl Pediatr       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.